Continuing education · Psychedelic-assisted therapy
The bridge between psychedelic research and clinical practice.
A rigorous, interdisciplinary training pathway for the clinicians shaping the next era of mental-health care, grounded in pharmacology, psychotherapy, ethics, and supervised practice.
Positioning
The therapeutic potential of psilocybin, MDMA, and ketamine is no longer fringe. It is an active frontier of psychiatric medicine. What clinicians need now is not more enthusiasm, but a structured pathway that integrates science, medicine, and healing into a single coherent training.
Evidence-informed. Supervised. Interdisciplinary by design.
Who this is for
Eight disciplines, one shared standard of care.
Psychiatrists
Prescribing frameworks, screening, and risk stratification for ketamine and trial-phase compounds.
Primary-care physicians
Recognize candidacy, manage comorbidity, and coordinate referral within scope of practice.
Registered nurses
Session monitoring, physiological safety, and dosing-day care protocols.
Social workers
Preparation, integration therapy, and psychosocial support across the arc of care.
Researchers
Trial design literacy, outcome measures, and translation of findings into practice.
Palliative-care specialists
Existential distress protocols and end-of-life applications with medical fragility in mind.
Indigenous leaders & healers
Reciprocal dialogue on lineage, ceremony, and consent in clinical settings.
Underground practitioners
Harm reduction, ethics, boundaries, and pathways toward regulated practice.
Modalities
Three compounds. Three very different clinical realities.
C12H17N2O4P
Psilocybin
Studied primarily in depression and end-of-life distress. We cover the current evidence base, session structure, and the screening that keeps participants safe.
C11H15NO2
MDMA
Trauma-focused protocols with a strong emphasis on cardiovascular screening, dyad therapy models, and evolving regulatory status.
C13H16ClNO
Ketamine
The one modality already in widespread clinical use. Routes of administration, monitoring standards, and integration between sessions.
CE / CME credits
Credit that holds up to your licensing board.
Coursework is delivered in live grand-rounds sessions and self-paced modules. Credit eligibility varies by discipline and jurisdiction; each session lists its designation before you register.
- Up to 64 hrs
AMA PRA Category 1
Physicians
- Up to 64 hrs
ANCC Contact Hours
Registered nurses
- Up to 48 hrs
ASWB ACE
Social workers
- Up to 48 hrs
APA Continuing Education
Psychologists
Our approach
Safety First
Patient safety, clinical rigor, and ethical integrity govern every module, every practicum hour, and every case discussion.
Evidence-Informed
We teach from the best available research and name its limits plainly, leaving room for inquiry, debate, and new findings.
Community & Collaboration
Better care emerges when clinicians, researchers, educators, and traditional practitioners learn across disciplines together.
Live grand rounds
Case-based sessions, every other week.
Faculty
Taught by people who do the work.
Dr. Amara Osei
MD, FRCPC
Psychiatry, trial safety
Rowan Vasquez
LCSW
Preparation & integration
Dr. Hana Petrov
PhD
Ethics & consent
Dr. Elias Mbeki
MD
Ketamine practice
Outcomes
“The practicum was the part I could not get anywhere else. Reading trial data is one thing; sitting with a patient through hour four is another.”
Dr. Priya Raman
MD, Consultation-liaison psychiatry
“It treated me as a clinician, not a convert. The ethics module alone reshaped how our team writes consent.”
Marcus Delaney
LCSW, Community mental health
“The interdisciplinary rooms were the point. I learned as much from the palliative nurses as from the pharmacology faculty.”
Dr. Yuki Tanaka
PhD, Clinical research
The library
Reading, listening, and clinic-ready protocols.
Twelve papers every prescribing clinician should know
Grand Rounds, Ep. 14: Boundaries in non-ordinary states
Train for the practice you will actually be doing in five years.
Applications reviewed on a rolling basis · Next cohort begins April